287 related articles for article (PubMed ID: 32633024)
21. Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism.
Zhang SQ; Yung KK; Chung SK; Chung SS
Cancer Sci; 2018 Jun; 109(6):1970-1980. PubMed ID: 29617059
[TBL] [Abstract][Full Text] [Related]
22. Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.
Ramana KV; Srivastava SK
Cytokine; 2006 Nov; 36(3-4):115-22. PubMed ID: 17174561
[TBL] [Abstract][Full Text] [Related]
23. Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition.
Liu M; Qin X; Li J; Jiang Y; Jiang J; Guo J; Xu H; Wang Y; Bi H; Wang Z
Phys Chem Chem Phys; 2024 Mar; 26(12):9295-9308. PubMed ID: 38469695
[TBL] [Abstract][Full Text] [Related]
24. [Aldo-keto reductase 1 member B1 (AKR1B1) inhibits retinal ganglion cell activity via activating NF-κB pathway and inducing mouse BV-2 microglia activation].
Bai Q; Wang X; Mao X; Hu D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1063-1068. PubMed ID: 33325358
[TBL] [Abstract][Full Text] [Related]
25. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.
Kabir A; Endo S; Toyooka N; Fukuoka M; Kuwata K; Kamatari YO
J Biochem; 2017 Feb; 161(2):215-222. PubMed ID: 28003428
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10.
Zhang W; Wang L; Zhang L; Chen W; Chen X; Xie M; Yan G; Hu X; Xu J; Zhang J
Steroids; 2014 Aug; 86():39-44. PubMed ID: 24793566
[TBL] [Abstract][Full Text] [Related]
28. (-)-Kusunokinin as a Potential Aldose Reductase Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation.
Tanawattanasuntorn T; Thongpanchang T; Rungrotmongkol T; Hanpaibool C; Graidist P; Tipmanee V
ACS Omega; 2021 Jan; 6(1):606-614. PubMed ID: 33458512
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
[TBL] [Abstract][Full Text] [Related]
30. Expression of interferon-stimulated gene 15-kDa protein, cyclooxygenase (COX) 1, COX-2, aldo-keto reductase family 1, member B1, and prostaglandin E synthase in the spleen during early pregnancy in sheep.
Yang L; Liu Y; Lv W; Wang P; Wang B; Xue J; Zhang L
Anim Sci J; 2018 Nov; 89(11):1540-1548. PubMed ID: 30191656
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
Soda M; Hu D; Endo S; Takemura M; Li J; Wada R; Ifuku S; Zhao HT; El-Kabbani O; Ohta S; Yamamura K; Toyooka N; Hara A; Matsunaga T
Eur J Med Chem; 2012 Feb; 48():321-9. PubMed ID: 22236472
[TBL] [Abstract][Full Text] [Related]
32. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.
Srivastava SK; Yadav UC; Reddy AB; Saxena A; Tammali R; Shoeb M; Ansari NH; Bhatnagar A; Petrash MJ; Srivastava S; Ramana KV
Chem Biol Interact; 2011 May; 191(1-3):330-8. PubMed ID: 21354119
[TBL] [Abstract][Full Text] [Related]
33. Targeting aldose reductase for the treatment of cancer.
Tammali R; Srivastava SK; Ramana KV
Curr Cancer Drug Targets; 2011 Jun; 11(5):560-71. PubMed ID: 21486217
[TBL] [Abstract][Full Text] [Related]
34. Artichoke Leaf Extract Inhibits AKR1B1 and Reduces NF-κB Activity in Human Leukemic Cells.
Miláčková I; Kapustová K; Mučaji P; Hošek J
Phytother Res; 2017 Mar; 31(3):488-496. PubMed ID: 28127803
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
Takemura M; Endo S; Matsunaga T; Soda M; Zhao HT; El-Kabbani O; Tajima K; Iinuma M; Hara A
J Nat Prod; 2011 May; 74(5):1201-6. PubMed ID: 21561086
[TBL] [Abstract][Full Text] [Related]
36. Regulation of AKR1B1 by thyroid hormone and its receptors.
Liao CS; Tai PJ; Huang YH; Chen RN; Wu SM; Kuo LW; Yeh CT; Tsai MM; Chen WJ; Lin KH
Mol Cell Endocrinol; 2009 Aug; 307(1-2):109-17. PubMed ID: 19422879
[TBL] [Abstract][Full Text] [Related]
37. AKR1B1 Upregulation Contributes to Neuroinflammation and Astrocytes Proliferation by Regulating the Energy Metabolism in Rat Spinal Cord Injury.
Chen X; Chen C; Hao J; Qin R; Qian B; Yang K; Zhang J; Zhang F
Neurochem Res; 2018 Aug; 43(8):1491-1499. PubMed ID: 29948725
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7.
Kabututu Z; Manin M; Pointud JC; Maruyama T; Nagata N; Lambert S; Lefrançois-Martinez AM; Martinez A; Urade Y
J Biochem; 2009 Feb; 145(2):161-8. PubMed ID: 19010934
[TBL] [Abstract][Full Text] [Related]
39. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium.
Bresson E; Boucher-Kovalik S; Chapdelaine P; Madore E; Harvey N; Laberge PY; Leboeuf M; Fortier MA
J Clin Endocrinol Metab; 2011 Jan; 96(1):210-9. PubMed ID: 20943776
[TBL] [Abstract][Full Text] [Related]
40. The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer.
Di Benedetto C; Borini Etichetti C; Cocordano N; Cantoia A; Arel Zalazar E; Bicciato S; Menacho-Márquez M; Rosano GL; Girardini J
Front Mol Biosci; 2023; 10():1145279. PubMed ID: 37780210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
